High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus

被引:74
作者
Romagnani, P
Annunziato, F
Manetti, R
Mavilia, C
Lasagni, L
Manuelli, C
Vannelli, GB
Vanini, V
Maggi, E
Pupilli, C
Romagnani, S
机构
[1] Univ Florence, Ist Med Interna & Immunoalllergol, I-50134 Florence, Italy
[2] Univ Florence, Dept Clin Physiopathol, Endocrinol Unit, I-50134 Florence, Italy
[3] Univ Florence, Dept Anat, I-50134 Florence, Italy
[4] Apuano Pediat Hosp, Massa Carrara, Italy
关键词
D O I
10.1182/blood.V91.9.3323.3323_3323_3332
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD30 is a member of tumor necrosis factor (TNF) receptor superfamily that is expressed by activated T cells in the presence of interleukin-4 (IL-4). Although CD30 can mediate a variety of signals, CD30-deficient mice have impaired negative selection of T cells, suggesting that at least in the context of murine thymus, CD30 is a cell death-mediating molecule. The ligand for CD30 (CD30L) is a membrane-associated glycoprotein related to TNF, which is known to be expressed mainly by activated T cells and other leukocytes. However, the nature of CD30L-expressing cells involved in the interaction with CD30+ thymocytes is unclear. We report here that in postnatal human thymus the great majority of CD30+ cells are double positive (CD4+CD8+), activated, IL-4 receptor-expressing T cells which selectively localize in the medullary areas. Moreover, many medullary epithelial cells and Hassal's corpuscles in the same thymus specimens showed unusually high expression of CD30L in comparison with other lymphoid or nonlymphoid tissues. These findings provide additional information on the nature and localization of CD30+ thymocytes and show that epithelial cells are the major holder of CD30L in the thymic medulla. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:3323 / 3332
页数:10
相关论文
共 30 条
[1]   Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice [J].
Amakawa, R ;
Hakem, A ;
Kundig, TM ;
Matsuyama, T ;
Simard, JJL ;
Timms, E ;
Wakeham, A ;
Mittruecker, HW ;
Griesser, H ;
Takimoto, H ;
Schmits, R ;
Shahinian, A ;
Ohashi, PS ;
Penninger, JM ;
Mak, TW .
CELL, 1996, 84 (04) :551-562
[2]   Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells [J].
Annunziato, F ;
Manetti, R ;
Cosmi, L ;
Galli, G ;
Heusser, CH ;
Romagnani, S ;
Maggi, E .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (09) :2239-2244
[3]  
Bowen MA, 1996, J IMMUNOL, V156, P442
[4]   CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2-mediated condition [J].
Chilosi, M ;
Facchetti, F ;
Notarangelo, LD ;
Romagnani, S ;
DelPrete, G ;
Almerigogna, F ;
DeCarli, M ;
Pizzolo, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (02) :329-334
[5]   In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells [J].
DElios, MM ;
Romagnani, P ;
Scaletti, C ;
Annunziato, F ;
Manghetti, M ;
Mavilia, C ;
Parronchi, P ;
Pupilli, C ;
Pizzolo, G ;
Maggi, E ;
DelPrete, GF ;
Romagnani, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 61 (05) :539-544
[6]   PREFERENTIAL EXPRESSION OF CD30 BY HUMAN CD4(+) T-CELLS PRODUCING TH2-TYPE CYTOKINES [J].
DELPRETE, G ;
DECARLI, M ;
ALMERIGOGNA, F ;
DANIEL, CK ;
DELIOS, MM ;
ZANCUOGHI, G ;
VINANTE, F ;
PIZZOLO, G ;
ROMAGNANI, S .
FASEB JOURNAL, 1995, 9 (01) :81-86
[7]  
FERNANDEZ E, 1994, BLOOD, V83, P3245
[8]   IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION [J].
GAVRIELI, Y ;
SHERMAN, Y ;
BENSASSON, SA .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :493-501
[9]  
Gruss HJ, 1996, AM J PATHOL, V149, P469
[10]  
GRUSS HJ, 1994, BLOOD, V83, P2045